• Market Access and Its Impact on Decision Making In Spain. An Example In Acute Myeloid Leukemia

    Oct 1, 2017, 00:00

  • Access to New Treatments For Chronic Hepatitis C in Four Latin American Countries

    Oct 1, 2017, 00:00

  • Modeling Covariate-Adjusted Survival for Economic Evaluations in Oncology

    Oct 1, 2017, 00:00

  • Dose Increase Beyond Labelled Dose of Biologic Treatments In Psoriasis Patients- A Real-World Study In Sweden

    Oct 1, 2017, 00:00

  • Assessing The Burden Of Chronic Heart Failure (Chf) On Patients In Brazil

    Oct 1, 2017, 00:00

  • Assessing Cost-Effectiveness And Key Value Drivers of Adjuvant Triglyceride Lowering Therapy In Management of Patients with A Rare Genetic Syndrome

    Oct 1, 2017, 00:00

  • Treatment Sequencing for Patients With Multiple Myeloma with at Least One Prior Line- Comparing Progression-Free Survival and Costs Under a Private Payer Perspective

    Oct 1, 2017, 00:00

  • Enhancement Program For Couples Adjustment To Failed Assisted Reproductive Technology

    Oct 1, 2017, 00:00

  • Assessing The Implications Of The Nice Budget Impact Test- How Many Oncology Regimens Will Be Affected And What Will Be The Impact On Patient Outcomes?

    Oct 1, 2017, 00:00

  • Using Electronic Health Records As A Real World Comparator- A Case Study In A Single Arm Oncology Trial

    Oct 1, 2017, 00:00

  • Treatment Cost of Hepatocellular Carcinoma from The Health Insurance’s Perspective in Viet Nam

    Oct 1, 2017, 00:00

  • What Do The Single Technology Appraisals of The Past Tell US About Fast-Tracking The Most Cost-Effective New Technologies In The Future?

    Oct 1, 2017, 00:00

  • Effect of Pharmacist Care on Medication Adherence and Cardiovascular Outcomes Among Patients Post-Acute Coronary Syndrome- A Systematic Review

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Surgical Approaches Total HIP Arthroplasty

    Oct 1, 2017, 00:00

  • Review Of Reimbursement Decision Drivers For Rare Cancer Therapies Across EU5 Markets

    Oct 1, 2017, 00:00

  • Cost And Operational Efficiency Comparison Of An Integrated VS. A Multi-Step System For Extracorporeal Photopheresis In Germany

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of Fidaxomicin Versus Vancomycin And Metronidazole In Patients With Clostridium Difficile Infection In Spain

    Oct 1, 2017, 00:00

  • Abaloparatide For Risk Reduction of Nonvertebral And Vertebral Fractures In Postmenopausal Women With Osteoporosis- A Network Meta-Analysis

    Oct 1, 2017, 00:00

  • Biologic Uptake Trends In Rheumatoid Arthritis

    Oct 1, 2017, 00:00

  • Burden of Disease for Psoriasis In Argentina, Brazil, Colombia and Mexico

    Oct 1, 2017, 00:00

  • Burden Of Diabetes Mellitus In Patients With Acromegaly Treated With Second-Line Pharmacotherapy In Spain

    Oct 1, 2017, 00:00

  • Repellent And Larvicidal Activity Of Thai Medicinal Plants Against Mosquitoes- A Systematic Review And Meta-Analysis

    Oct 1, 2017, 00:00

  • Racial Disparities in Treatment of Pregnant Women with Drug Use, Abuse and Dependence

    Oct 1, 2017, 00:00

  • Utilization and Treatment Patterns Among Patients with Advanced Non-Small Cell Lung Cancer Receiving Predictive Molecular Biomarker (BMX) Tests

    Oct 1, 2017, 00:00

  • Diferencias Geográficas En La Salud Auto-Percibida Comunal De Chile

    Oct 1, 2017, 00:00

  • Non-Proportional Hazards in Network Meta-Analysis- Efficient Strategies for Model Building and Analysis

    Oct 1, 2017, 00:00

  • Identifying the Challenges to Adult Influenza Vaccination in Latin America

    Oct 1, 2017, 00:00

  • 2017 Black Box Amnog Rebates- What Is Driving The Rebates?

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of Insulin Degludec Versus Insulin Glargine U100 In Type 1 And Type 2 Diabetes Patients From The Portuguese National Healthcare System Perspective- Evidence From The Switch 12 Trials

    Oct 1, 2017, 00:00

  • Generic Competition and ITS Impact on Reference Pricing System and Medicnes Utilization in the Group of Sartans

    Oct 1, 2017, 00:00

  • Resource Utilisation And Related Health Care Costs Among Patients With Multiple Myeloma With ≥ 2 Prior Lines Of Treatment In Finland- Evaluation Based On Finnish Real World Data From Auria Biobank

    Oct 1, 2017, 00:00

  • Open Tibial Fractures With Segmental Defects- A U.S. Retrospective Database Analysis Examining 12-Month Post-Operative Patient Outcomes And Costs

    Oct 1, 2017, 00:00

  • Treatment Patterns Of Second-Line (2L) Metastatic Urothelial Cancer (MUC) In Spain

    Oct 1, 2017, 00:00

  • One Year Cost Of Ischemic Stroke And Intracranial Hemorrage According To Disability For Atrial Fibrillation Patients In France

    Oct 1, 2017, 00:00

  • The Associated Factors of Neuropathic Pain Among Chronic Low Back Pain Patients in South Korea- Findings from the NLBP OR

    Oct 1, 2017, 00:00

  • Real-World Health Care Expenditure In Hemophilia A Patients Using Standard And Extended Half-Life Recombinant Factor VIII Products

    Oct 1, 2017, 00:00

  • Impact of Disease Activity Measures on Health Utilities in PPMS

    Oct 1, 2017, 00:00

  • Health-Related Quality of Life in Patients with Metastatic Colorectal Cancer Using EQ-5D-5L

    Oct 1, 2017, 00:00

  • Barriers To Access And Pricing Negotiations Criterial Selection For Novel Treatments For Hepatitis C In The Greek Healthcare Context

    Oct 1, 2017, 00:00

  • A Systematic Literature Review of Uk Epidemiology of Brca1 And BRCA2-Mutated Locally Advanced or Metastatic Ovarian Cancer

    Oct 1, 2017, 00:00

  • Primary Treatment Patterns Among Glaucoma Patients In Korea From 2002 To 2013 Using The National Health Insurance System Claims Data

    Oct 1, 2017, 00:00

  • The Use of The Propensity Score In The Cost-Effectiveness Analysis of The Atrial Fibrillation Treatment

    Oct 1, 2017, 00:00

  • Cost and Treatment of Asthma and Copd in the Real Practi A Regional Segmentation

    Oct 1, 2017, 00:00

  • Review Of The Reimbursement Environment For Advanced Therapeutic Medicinal Products (AtmpS) In The Uk

    Oct 1, 2017, 00:00

  • Value of Needleless Safety Devices For IV Voriconazole In Prevention of Needlestick Injury (NSI)

    Oct 1, 2017, 00:00

  • Integrated Care System For Hypertension In China- What The Cost Will Be For Government? A budget impact analysis

    Oct 1, 2017, 00:00

  • Programa Stewardship- Otimizando A Terapia Antimicrobiana Com Eficiência Em Um Hospital De Ensino De Referência Em Fortaleza, Ceará

    Oct 1, 2017, 00:00

  • Market Access of Advanced Therapy Medicinal Product (ATMP) In Europe- Lessons Learnt And Key Considerations for Future Success

    Oct 1, 2017, 00:00

  • Primary Data Collection Versus use of Retrospective Claims Data- Methodology Lessons Learned from A Linked Database Study in Chronic Obstructive Pulmonary Disease (COPD)

    Oct 1, 2017, 00:00

  • Estimation of The Cost of Metastatic Melanoma in France Using Melbase Data

    Oct 1, 2017, 00:00

  • Primary Nonadheren Do Differences Exist Between Life Sustaining And Quality Of Life Medications?

    Oct 1, 2017, 00:00

  • An Economic Model To Support Decisions on The Adoption of A Live Vaccine To Aid in The Control of Salmonid Rickettsial Septicaemia (Srs) In Farmed Atlantic Salmon in Chile

    Oct 1, 2017, 00:00

  • Incorporating Dependence Between Model Parameters In Uncertainty Analyses

    Oct 1, 2017, 00:00

  • The Economic Impact Of Providing Dengue Vaccination In The Workplace In Brazil

    Oct 1, 2017, 00:00

  • Evaluating The Addition To Formulary of Belimumab For The Treatment of Systemic Lupus Erythematosus- A Cost-Effectiveness Model

    Oct 1, 2017, 00:00

  • Cost-Utility Evaluation Of Insulin Glargine (300 U/ML) Versus Insulin Glargine (100 U/ML) And Insulin Degludec (100 U/ML) In Patients With Type 2 Diabetes Mellitus In Slovenia

    Oct 1, 2017, 00:00

  • Pre-Hospital Pain Relief Treatment In Patients With Musculoskeletal Injuries Experiencing Moderate To Severe Pain In Medical Emergencies

    Oct 1, 2017, 00:00

  • Obstructive Sleep Apnea Treatment Guidelines - Implementation Status In Oecd-Countries

    Oct 1, 2017, 00:00

  • Consistency Assessment of International Drug Price Comparisons

    Oct 1, 2017, 00:00

  • The Validity of Objective Response Rate As A Surrogate For Progression-Free And Overall Survival In The Evaluation of First-Line Chemotherapy For Advanced Non-Small Cell Lung Cancer

    Oct 1, 2017, 00:00

  • Lipid-Lowering Treatment Patterns and Possible Associated Statin Intolerance in Patients with Clinical Atherosclerotic Cardiovascular Disease (ASCVD) or Diabetes Mellitus (DM) in Taiwan

    Oct 1, 2017, 00:00

  • Healthcare Costs Associated with Cervical Cancer, Precancerous Lesions, and Genital Warts Treatment in Taiwan

    Oct 1, 2017, 00:00

  • Estimating Survival After Radical Prostatectomy In Prostate Cancer; A Propensity-Score Matching Method

    Oct 1, 2017, 00:00

  • Innovative Contracting- Use Of Complex Managed Entry Agreements

    Oct 1, 2017, 00:00

  • The Cost and Outcomes of Breast Cancer Screening for Women 40-49 Years Old in Russia

    Oct 1, 2017, 00:00

  • Comparative Effectiveness Of Novel Treatments For Advanced Melanoma- A Systematic Literature Review And Network Meta-Analysis Of Effectiveness And Safety Outcomes

    Oct 1, 2017, 00:00

  • Social Burden of Copd

    Oct 1, 2017, 00:00

  • Market Dynamics of Statin Medications

    Oct 1, 2017, 00:00

  • Comparative Analysis of Lists of Antifungal Preparations for Onychomycosis Treatment In British and Ukrainian National Formularies

    Oct 1, 2017, 00:00

  • A Population-Based Study on Clinical Outcomes and Medical Costs of Laparoscopic Versus Open Surgery for Colon Cancer Patients in Taiwan

    Oct 1, 2017, 00:00

  • Length of Trial Period and Fit of Standard Survival Extrapolation Distributions for Ipilimumab in Melanoma

    Oct 1, 2017, 00:00

  • Is Willingness to Pay Higher for Cancer Prevention and Treatment?

    Oct 1, 2017, 00:00

  • The Value Of Beds With Continuous Lateral Rotation Therapy To Prevent Ventilator-Associated Pneumonia And Pressure Injuries- A Cost-Effectiveness Analysis

    Oct 1, 2017, 00:00

  • Comparisons Of Healthcare Utilization And Cost Impact Of Managing Type 2 Diabetes Across The System Of Care In Medicare Beneficiaries

    Oct 1, 2017, 00:00

  • Evaluating Health Impact Of Common Chronic Conditions On Quality Of Life Of EQ-5D-3L In Older Chinese

    Oct 1, 2017, 00:00

  • Alemtuzumab Is The Most Cost-Effective Option In Comparison To Available Therapies In The Treatment of Rrms From The UK NHS Perspective

    Oct 1, 2017, 00:00

  • Electronic Patient-Reported Outcomes- Are There Gaps Between Guidance And Issues Encountered In Practice?

    Oct 1, 2017, 00:00

  • Systematic Literature Review And Indirect Comparison of Glasdegib Plus Low Dose ARA-C Versus A Hypomethylating Agent For Acute Myeloid Leukemia Patients Ineligible For Intensive Chemotherapy

    Oct 1, 2017, 00:00

  • The Examination Of Location And Frequency Of Pain In Weight Training

    Oct 1, 2017, 00:00

  • Substantiation of the National Policy of Pricing and Availability of Drugs

    Oct 1, 2017, 00:00

  • Discrete Event Simulation Modelling of Long Term Cost-Effectiveness of Internet-Based Blended Cognitive Behavioural Therapy for Major Depressive Disorder- Extrapolation of the E-Compared Randomised Controlled Trial

    Oct 1, 2017, 00:00

  • Persistence and Adherence to Oral Antiresorptive Therapy in a Fracture Liaison Servi 24-Month Results of a Prospective Cohort Study

    Oct 1, 2017, 00:00

  • The Need For Developing A Decision Aid Tool About Feeding Options

    Oct 1, 2017, 00:00

  • Review of Surrogate Endpoint Validation Methodologies and Application In Solid Tumour Htas

    Oct 1, 2017, 00:00

  • Prevalence of Overweight and Obesity Among Health Personnel in an Urban Ghana- A Descriptive Cross-Sectional Study, 2017

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Continuous Versus Intermittent Celecoxib Use for HIP and Knee Osteoarthritis

    Oct 1, 2017, 00:00

  • A Systematic Review Of Calibration In Population Models

    Oct 1, 2017, 00:00

  • The Burden of Spondyloarthritis – Paasport A Population-Based Study

    Oct 1, 2017, 00:00

  • The Comparison Among Different Countries’ EQ-5D-5L Value Sets Applied In Chinese General Population

    Oct 1, 2017, 00:00

  • Development of a Screening Questionnaire to Detect Heavy Menstrual Bleeding in Women of Child-Bearing Age

    Oct 1, 2017, 00:00

  • Retrospective Analysis of the Use of Incremental Cost-Effectiveness Ratio (Icer) in Technology Incorporation in the Brazilian Public Health System (Sus), 2012-2016, Perspectives and Challenges for the Brazilian Context

    Oct 1, 2017, 00:00

  • Minimally Important Differen Empirical Comparison Of Estimation Methods Using Orthopaedics And Otolaryngology

    Oct 1, 2017, 00:00

  • Are LABA/LAMA/ICS FDCS A Triple Threat for COPD Competitors in the Cost-Constrained EU5?

    Oct 1, 2017, 00:00

  • Pro Instruments Used in Studies of Skin Cancer Since 1960

    Oct 1, 2017, 00:00

  • Measurement Of Multimorbidity To Predict All-Cause Mortality In A Nationwide Population, Using The French National Health Insurance Database (SNIIRAM)

    Oct 1, 2017, 00:00

  • Development Of A Tool To Quantify An Individual’s History Of Sun Exposure- Qualitative Phase Of The Development Of The Sun Exposure Questionnaire

    Oct 1, 2017, 00:00

  • ASSOCIATION Between Second-Line Therapy (2LT) Regimen Type, Duration of Therapy (DOT), and Time To Next Treatment (TTNT) In A United States (US) Relapsed/Refractory Multiple Myeloma (RRMM) Cohort- An Electronic Medical Records (EMR)-Based S ...

    Oct 1, 2017, 00:00

  • Willingness To Pay For Qaly In The Czech Republic Between 2013 And 2017- A Review

    Oct 1, 2017, 00:00

  • Angiotensin II Receptor Blockers And Intestinal Malabsorption- An Observational Cohort Study In Germany And Italy

    Oct 1, 2017, 00:00

  • Value Of Treating All Liver Fibrosis Stages To Reach Elimination Of Diagnosed Chronic Hepatitis C- A Modelling Approach In France

    Oct 1, 2017, 00:00

  • Approaches To Modelling The Cost-Effectiveness Of Interventions For Heart Failure- A Systematic Review

    Oct 1, 2017, 00:00

  • Economic Evaluation of Romiplostim Vs Eltrombopag In The Treatment of Adult Patients With Chronic Immune Thrombocytopenia In Mexico

    Oct 1, 2017, 00:00

  • Healthcare Professionals’ Preferences for the Treatment Selection of Chronic Lymphocytic Leukemia (CLL)- The Prelic Study

    Oct 1, 2017, 00:00

  • Increasing Trend On Turkish Un-Licenced Medicine Market- A General Overview Analysis

    Oct 1, 2017, 00:00

  • Cost-Utility Analysis of A Novel Breath-Triggered Aerosol Inhaler Which Has Been Designed To Reduce The Critical Handling Error of Insufficient Inspiratory Effort

    Oct 1, 2017, 00:00

  • A Healthcare Policy Study To Build A Roadmap for Rare Disease Management Under The Egyptian Healthcare System

    Oct 1, 2017, 00:00

  • Impacto De Una Ley De Bioequivalencia En El Precio De Medicamentos

    Oct 1, 2017, 00:00

  • New Insights In Metastatic Colorectal Cancer Treatment (MCRC) In 5 European Countries

    Oct 1, 2017, 00:00

  • Non-Quantifiable Benefit Within The German Amnog System- Factors Contributing To Time Limits Set For Benefit Resolutions And Potential Implications On Price Discounts

    Oct 1, 2017, 00:00

  • External Validation of A Mapping Algorithm To Estimate Eq-5d-3l Utilities From Oxford Knee Score Responses

    Oct 1, 2017, 00:00

  • Long-Term Benefits of LDL Cholesterol Lowering In Young Adulthood- A Computer Simulation Study

    Oct 1, 2017, 00:00

  • Comparison of The Quality of Life In Elderly Population According To The Occurrence of Femoral Neck Fracture

    Oct 1, 2017, 00:00

  • The Cost Of Treating Diabetic Ketoacidosis In The UK- A National Survey Of Hospital Resource Use

    Oct 1, 2017, 00:00

  • Overall Survival In Patients With Metastatic Urothelial Cancer By First-Line Therapy

    Oct 1, 2017, 00:00

  • Patterns of Estimated Glomerular Filtration Rate and Albuminuria in Relation to Progression to Serious Outcomes- Hospitalization for Infection, Major Adverse Cardiovascular Events and Renal Failure

    Oct 1, 2017, 00:00

  • Direct Oral Anticoagulant (DOAC) Adoption in Practi Utilization, Expenditures, Switching and Adherence

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Easypod™ Device Versus Other Somatotropin Delivery Techniques In Egypt In Treatment of Growth Hormone Deficiency

    Oct 1, 2017, 00:00

  • Risk of Dipeptidyl-Peptidase-4 (Dpp-4) Inhibitors On Site-Specific Cancer- A Systematic Review And Meta-Analysis

    Oct 1, 2017, 00:00

  • Issues Encountered When Modelling The Long Term Clinical Effectiveness Of Treatments From Short Term Trials Using Second-Line Treatments For Advanced Or Metastatic Renal Cell Carcinoma (AMRCC) As An Example

    Oct 1, 2017, 00:00

  • Vaccines for Herpes Zoster- A Systematic Review of Randomized Controlled Trials In Adults ≥50 Years of Age

    Oct 1, 2017, 00:00

  • Impact Of Genomic Testing Billing Practices On Utilization In Academic Hybrid Oncology Practice

    Oct 1, 2017, 00:00

  • Statistics and Costs of Emergency Care Related to External Causes in One Hospital of Rio De Janeiro City

    Oct 1, 2017, 00:00

  • Comparison Of Costs Between Hospital And Home Infusions In Patients Treated With Laronidase

    Oct 1, 2017, 00:00

  • Competency Analysis Of Community Pharmacists About Correct Use Of Metered Dose Inhaler

    Oct 1, 2017, 00:00

  • A Cost Consequences Analysis of The Human Body Posturizer In Italy

    Oct 1, 2017, 00:00

  • Supporting Individual Reflection and Patient-Clinician Shared Decision-Making on GEP-NET Management Options Using Reflective Multi-Criteria Decision Analysis

    Oct 1, 2017, 00:00

  • Real World Data on Multiple Myeloma Treatment Patterns- First and Second-Line Treatment in the Brazilian Public Health System

    Oct 1, 2017, 00:00

  • Trends in Pragmatic Clinical Trials

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of Invasive Fungal Infections Therapies In Febrile Neutropenic Patients With Hematological Malignancies In The Turkish Context

    Oct 1, 2017, 00:00

  • Biosimilars And Reference Biotechnologic Drugs- Comparison Of The Biosimilars’ Effect On Reference Drug’s Price For EU, USA And Turkey

    Oct 1, 2017, 00:00

  • A Cost Effectiveness Analysis Of Seasonal Quadrivalent Influenza Vaccine In Italy Using A Static Model

    Oct 1, 2017, 00:00

  • Real World Evidence In Europe - The Results Of An Expert Survey

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Prasugrel For Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention In Spain

    Oct 1, 2017, 00:00

  • An Observational Retrospective Cohort Database Study To Estimate Costs Regarding Immunoglobulin Use for Itp Treatment In The Brazilian Public Healthcare System

    Oct 1, 2017, 00:00

  • Oral Estrogen Therapy Is Associated With Reduced Risk of Hepatitis B Virus–Related Hepatoma In Taiwanese Postmenopausal Women

    Oct 1, 2017, 00:00

  • Efetividade Na Solicitação De Exames Laboratoriais Na Atenção Básica

    Oct 1, 2017, 00:00

  • Patient Counts Based on The Most Commonly Funded Diseases In Home Special Care In Hungary, 2013

    Oct 1, 2017, 00:00

  • Breakfast Consumption And Associated Factors Among Students In Olabisi Onabanjo University, Ogun State, Nigeria

    Oct 1, 2017, 00:00

  • Relevance Of Real World Data In German Amnog Submissions In Oncology

    Oct 1, 2017, 00:00

  • Review of Rare Disease Registries Across EU5 Countries

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of A Direct Aspiration First Pass Technique (ADAPT) For Thrombectomy Revascularization of Large Vessel Occlusion In Acute Ischemic Stroke (French Health Ministry Prme 16-0020)

    Oct 1, 2017, 00:00

  • Indirect Costs and Caregiver Burden of Schizophrenia In European Countries – Results of A Systematic Literature Review

    Oct 1, 2017, 00:00

  • Recent Trends in Provider Perceptions and Use of Value Frameworks in the United States (US)

    Oct 1, 2017, 00:00

  • Pharmacoeconomic Analisys of Obinutuzumab Plus Chlorambucil in Patients with Previously Untreated Chronic Lymphocytic Leukemia and Coexisting Conditions

    Oct 1, 2017, 00:00

  • Calculating The Indirect Costs Of Adult Pneumococcal Disease And The Rate Of Return To The 13-Valent Pneumococcal Conjugate Vaccine (PCV13) In Older Adults, With An Application To Denmark

    Oct 1, 2017, 00:00

  • Estudio De Costo- Consecuencia De Darbepoetina Alfa Para EL Tratamiento De Anemia Sintomática Derivada De La Enfermedad Renal Crónica En Colombia

    Oct 1, 2017, 00:00

  • Leveraging Electronic Health Records to Meet The Real World Evidence Needs of Hta- A Uk Perspective

    Oct 1, 2017, 00:00

  • Assessment of Antidiabetic Drugs In Fran What Is The Basis For A Reimbursement Recommendation?

    Oct 1, 2017, 00:00

  • Acceptance of Population-Adjusted Indirect Treatment Comparison Methods In Nice Assessments

    Oct 1, 2017, 00:00

  • Incidence, Mortality And Treatment Of Melanoma In Poland In The Years 2012–2016

    Oct 1, 2017, 00:00

  • Uses and Applications of Eq-5d in Latin America the Caribbean- Systematic Review and Bibliometric Analysis

    Oct 1, 2017, 00:00

  • Health Technology Assessment Decisions in Immuno-Oncology Therapies- Results, Rationales, and Trends

    Oct 1, 2017, 00:00

  • Análise Da Qualidade Da Evidência Científica Entre Xelox E Folfox No Tratamento Do Câncer Colorretal

    Oct 1, 2017, 00:00

  • European Real World Data Sources To Characterise Flares In Patients With Systemic Lupus Erythematosus- A Review

    Oct 1, 2017, 00:00

  • The Cost-Effectiveness of IVF Treatments Gonal-F® Versus HP-HMG in the United Arab Emirates (UAE)

    Oct 1, 2017, 00:00

  • Switching Maintenance Infliximab Therapy to Biosimilar-Infliximab does Not Lead to Significant Changes in Health-Related Quality of Life and Clinical Outcomes in Inflammatory Bowel Disease Patients

    Oct 1, 2017, 00:00

  • Pharmatool- An Economic and Epidemiological Calculation Tool To Aid Planning For Reducing Cardiovascular Morbidity In Brazil

    Oct 1, 2017, 00:00

  • Impacto Económico En Las Patologías De Salud Mental, Neurológicas Y Demencias En Colombia

    Oct 1, 2017, 00:00

  • Comparative Analysis Of Health Technology Assessments Of Drugs For The Treatment Of Multiple Myeloma

    Oct 1, 2017, 00:00

  • Subcutaneous Immunoprophylaxis As A Cost-Effective Treatment Alternative For Hepatitis B Virus-Related Transplant Patients In France

    Oct 1, 2017, 00:00

  • The Economic Impact of Switching To Herceptin (TRASTUZUMAB) Biosimilar for The Treatment of Metastatic Breast Cancer From A UK Payer Perspective

    Oct 1, 2017, 00:00

  • Healthcare Resource Use And Economic Burden Attributable To Respiratory Syncytial Virus In The United States

    Oct 1, 2017, 00:00

  • Custo De Tratamento Biológico Em Pacientes Com Doenças Reumáticas Em Uma Operadora De Saúde De Fortaleza/Ce

    Oct 1, 2017, 00:00

  • Minimizing Bias In Indirect Comparisons Utilizing Virtual Patient Level Data

    Oct 1, 2017, 00:00

  • Health-Related Quality-Of-Life And Utility Measures Impact In A Randomized Controlled Study Of Fine Needle Aspiration Cytology (FNAC) Versus Watchful Observation In Patients With Incidental Symptomatic Thyroid Nodules

    Oct 1, 2017, 00:00

  • Price Life Cycle Management Of Orphan Drugs In France

    Oct 1, 2017, 00:00

  • Characterization Of Low Density Lipoprotein (LDL) Levels In Patients Diagnosed With Arterial Hypertension In Colombian Population In The Year 2016

    Oct 1, 2017, 00:00

  • The Economic Burden of Breast Cancer in Russia

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of Interferon-Free Treatment Strategies For Hepatitis C After Generic Entry Of Direct-Acting Antivirals In The Kazakhstan

    Oct 1, 2017, 00:00

  • Modelling The Burden Of Cardiovascular Disease In Turkey And The Impact Of Reducing Modifiable Risk Factors

    Oct 1, 2017, 00:00

  • Treatment in Transplant Eligible Multiple Myeloma Patients in Macedonia- Development of Cost-Effectiveness Analysis

    Oct 1, 2017, 00:00

  • German Amnog Benefit Assessment- The Type Of Appropriate Comparator Makes The Difference

    Oct 1, 2017, 00:00

  • The Economic Impact of Rheumatoid Arthritis on Patients’ Households. An Estimation of The Disease Related Catastrophic Health Expenditure, In Greece

    Oct 1, 2017, 00:00

  • Cost Analysis of Several Treatment Sequences Used for The Treatment of Relapsing-Remitting Multiple Sclerosis In Portugal- The Case for Cladribine Tablets

    Oct 1, 2017, 00:00

  • Positive Externalities of austerity? The Case of Smoking Cessation During the Financial Crisis in Greece

    Oct 1, 2017, 00:00

  • A Conceptual Yet Pragmatic Framework for Value-Based Agreements

    Oct 1, 2017, 00:00

  • Symptom Deterioration in Patients with Metastatic Renal Cell Carcinoma Treated with Cabozantinib or Everolimus

    Oct 1, 2017, 00:00

  • A Review of The Quality of Life and Educational Burden of Allergic Rhinitis on Adolescents

    Oct 1, 2017, 00:00

  • Copyright/Subscription

    Oct 1, 2017, 00:00

  • A Comparison Of Markov Cohort And Discrete Event Simulation Models In Cost-Effectiveness Analysis Of Sorafenib And Everolimus In 3rd Line Metastatic Renal-Cell Carcinoma In The Czech Republic

    Oct 1, 2017, 00:00

  • Evaluation of The Long-Term Cost-Effectiveness Of Real Time Continuous Glucose Monitoring (RTCGM) Versus Self Monitoring Of Blood Glucose (SMBG) Alone In Type 1 Diabetes From The Swedish Societal Perspective

    Oct 1, 2017, 00:00

  • Estimation Of Health-Related Quality Of Life (HRQOL) In Cancer Patients Utilising A Time-To-Death Analysis

    Oct 1, 2017, 00:00

  • Multivariate Network Meta-Analysis of Survival Function Parameters

    Oct 1, 2017, 00:00

  • Resultados De La Implementación De Una Estrategia Combinada De Educación Y Gestión De Pacientes En Centros De Atención Primaria De Argentina

    Oct 1, 2017, 00:00

  • Evaluation of Appropriateness of Antibiotics in the Intensive Care Unit of a Tertiary Care Hospital

    Oct 1, 2017, 00:00

  • Retrospective Analysis of The Burden of Cytomegalovirus Disease In Immunosuppressed Patients After Haematopoietic Cell Transplantation In England

    Oct 1, 2017, 00:00

  • Factors Affecting Polypharmacy in Elderly Patients with Diabetes in Greece

    Oct 1, 2017, 00:00

  • Understanding Stakeholder Expectations for Patient Engagement- A Qualitative Survey

    Oct 1, 2017, 00:00

  • Direct Costs of Long-Term Psychiatric Hospitalization in Public Hospital of the State of Sao Paulo, Brazil- The Complexo Hospitalar Juquery Case

    Oct 1, 2017, 00:00

  • Mixed Methods Evaluation of An Itch Numeric Rating Scale Among Adult and Adolescent Patients With Atopic Dermatitis

    Oct 1, 2017, 00:00

  • Progression-Free Survival as a Surrogate Endpoint for Overall Survival in Patients with Relapsed or Refractory Multiple Myeloma

    Oct 1, 2017, 00:00

  • Second-Line Treatments For Advanced Gastric Cancer- A Network Meta-Analysis Of Overall Survival Using Parametric Modelling Methods

    Oct 1, 2017, 00:00

  • Direct Costs of Health Care of Cystic Fibrosis, The Case of A Health Insurer In Colombia

    Oct 1, 2017, 00:00

  • Characteristics of Latin American Patients With Rheumatoid Arthritis Receiving Advanced Therapy

    Oct 1, 2017, 00:00

  • Comparing Quality of Life of (RT-PA) with No-(RT-PA) in Stroke Attacked Patients

    Oct 1, 2017, 00:00

  • Quality of Life and Economic Burden Among Chronic Obstructive Pulmonary Disease (Copd) Patients in Japan

    Oct 1, 2017, 00:00

  • Regional Policies Impact on Biosimilar Adoption For Autoimmune Diseases In Italy

    Oct 1, 2017, 00:00

  • Long Term Efficacy of Pertuzumab For HER2+ Metastasic Breast Cancer Ecuadorian Population

    Oct 1, 2017, 00:00

  • Special Considerations for Conducting Qualitative Interviews With Cancer Patients and Their Caregivers for The Purpose of Developing Clinical Outcome Assessments

    Oct 1, 2017, 00:00

  • Identification of Assessment and Funding Models Applicable to Companion Diagnostics in UK, France And Germany

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Posaconazole Versus Fluconazole in The Prophylaxis of Invasive Fungal Infections in Acute Leukemia Patients in Colombia

    Oct 1, 2017, 00:00

  • Costo De La Diabetes Mellitus En El Sistema De Salud Colombiano

    Oct 1, 2017, 00:00

  • The Role of Stakeholder Engagement in E-Health and the use of Big Data to Predict Health Outcomes

    Oct 1, 2017, 00:00

  • Cost Analysis Of Drug-Related Probelms In Saudi Arabia, Patient And Health Care Professional's Perspective

    Oct 1, 2017, 00:00

  • Exploring The Efficacy And Safety of Radiofrequency Ablation In Patients With Spinal Metastases- A Systematic Review

    Oct 1, 2017, 00:00

  • Which Are The Most Common Quality of Life Health States In Latin America? A Pareto Analysis of A Collaborative Project Using Euroqol Eq-5d In Argentina, Brazil, Chile and Uruguay

    Oct 1, 2017, 00:00

  • Integrated 2 Screw De-Rotation/Compression, Cepahlo-Medulary Device Reduces Implant Related Complications and Improves Health Related Quality of Life in Patients with Intertrochanteric Fractures, A Systematic Review and Meta-Analysis

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of Sacubitril/Valsartan In The Treatment Of Heart Failure In Colombia

    Oct 1, 2017, 00:00

  • Mapping Acroqol Scores to EQ-5D to Obtain Utility Values for Patients with Acromegaly

    Oct 1, 2017, 00:00

  • Coverage Evidence Development in the Course of the Drug Reevaluation in Korea

    Oct 1, 2017, 00:00

  • Systematic Literature Review of the Impact of Asthma Support Programs Dedicated to Adult Patients

    Oct 1, 2017, 00:00

  • Patients Acknowledge Adaptation- The Case Of Amputees

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Dabigatran with Real World Effectiveness Evidence

    Oct 1, 2017, 00:00

  • A Markov Microsimulation Model For The Economic Evaluation Of Partially Implantable Active Middle Ear Implants In Sensorineural Hearing Loss

    Oct 1, 2017, 00:00

  • Increased Episode Rate of Medically-Attended Acute Gastroenteritis In Diabetics In England

    Oct 1, 2017, 00:00

  • Selective Internal Radiotherapy (SIRT) in Metastatic Colorectal Cancer Patients with Liver Metastases- Preliminary Primary Care Resource Use and Utility Results from The Foxfire Randomised Controlled Trial

    Oct 1, 2017, 00:00

  • Horizon Scanning In Oncology – Rapid Scanning Approach In Slovakia

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Evaluation Of Phid-CV Versus PCV-13 In Slovakia

    Oct 1, 2017, 00:00

  • Factors Contributing to the Ceiling Effect Among Patients with Prostate Cancer who Were Judged to Have “Full-Health” by EQ-5D-5L

    Oct 1, 2017, 00:00

  • Exploring Structural Uncertainty With An Open-Source Cost-Effectiveness Model For Rheumatoid Arthritis

    Oct 1, 2017, 00:00

  • Comparison Of Costs And Care Of Lung Cancer Patient At The End-Of-Life In Germany Depending On The Time Of Survival After Diagnosis

    Oct 1, 2017, 00:00

  • Spirometry Comparison Between Smokers and Non-Smokers Students in University of Balochistan,Quetta, Pakistan

    Oct 1, 2017, 00:00

  • Analysis Of The Behavior Of The Expenditure Curve In Oncology And Other Causes Of Death In The Last 5 Years Of Life – Brazil Real-World Health Care Data

    Oct 1, 2017, 00:00

  • Cost Utility Analysis of Infliixmab and Adalimumab Compared with Conventional Therapy in Patients with Crohn Disease in the Islamic Republic of Iran

    Oct 1, 2017, 00:00

  • Cost Impact Analysis of Needlestick Injuries In India

    Oct 1, 2017, 00:00

  • Health-Economics Evaluations in France, England, Canada and Autralia- Comparison of Methodologies and Impact on Drugs’ Access To Patients

    Oct 1, 2017, 00:00

  • The Personalised Reimbursement Models (Prm)- Real World Data Collection to Provide Innovative Pricing Solutions in France

    Oct 1, 2017, 00:00

  • Burden and Cost of Cancer Treatment in the Private Healthcare Setting in São Paulo State

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Comparison of Opoid Substitution Therapy Vs. Non-Pharmcologic Therapy In The State of Kuwait

    Oct 1, 2017, 00:00

  • Association Between Socioeconomic Deprivation And Cancer Incidence And Outcomes Among English CCGS

    Oct 1, 2017, 00:00

  • Multiple Myeloma Patients’ Profile and Regimens Transitions in the Brazilian Private Health Sector

    Oct 1, 2017, 00:00

  • Agreement Between Patient And Clinician Ratings Of Disease Severity In Hidradenitis Suppurativa, Rheumatoid Arthritis, And Chronic Plaque Psoriasis

    Oct 1, 2017, 00:00

  • Economic Benefits of SFLT-1/PLGF Testing for Preeclampsia in Colombia- A Fiver Year Budget Impact Analysis

    Oct 1, 2017, 00:00

  • Do Characteristics of Patients Influencing the Choice of Pain Treatment by GPS Differ in Osteoarthritis and Cancer? – An Italian Real World Evidence Study

    Oct 1, 2017, 00:00

  • Indicators of Participation in Cervical Cancer Screening Among Romany Women

    Oct 1, 2017, 00:00

  • Cost-Utility Analysis of Rhtnk-TPA Compared With RT-PA In The Treatment of Acute St-Segment Elevation Myocardial Infarction (Stemi) In China

    Oct 1, 2017, 00:00

  • Prevalence of Cardiovascular Disease In Type 2 Diabetes- A Global Systematic Review

    Oct 1, 2017, 00:00

  • Utilization of Lipid-Lowering Drugs in Slovakia- Comparison of Data from Different Sources

    Oct 1, 2017, 00:00

  • Evaluation Of Wearable Technology Use In Clinician Outcomes Assessment Studies

    Oct 1, 2017, 00:00

  • Economic Burden of Hospitalizations Related To Pulmonary Arterial Hypertension (PAH) In France

    Oct 1, 2017, 00:00

  • Cost Effectiveness Of Pentaray High Density Mapping Catheter In Treatment Of Ventricular Tachycardia In Turkey

    Oct 1, 2017, 00:00

  • Demand And Supply Side Regulation Of Biosimilar Markets In Germany, France And England And Its Implications For Market Access Of Biosimilars

    Oct 1, 2017, 00:00

  • Probabilistic Sensitivity Analysis And Its Role In Assessment Of Profitability In Poland

    Oct 1, 2017, 00:00

  • Patient Reported Outcome Of Celiac Disease

    Oct 1, 2017, 00:00

  • Psoriasis (PSO) Patients’ Profile And Impact of The Disease on Patients’ Quality of Life and Work Productivity In A Real-Life Setting In Brazil

    Oct 1, 2017, 00:00

  • Sulfadiazine-Pyrimethamine Versus Sulfamethoxazole-Trimethoprim For Treatment of Toxoplasmic Encephalitis in Hiv/Aids Patients- A Cost Effectiveness Analysis

    Oct 1, 2017, 00:00

  • The Economic Impact of Dietary Sodium Reduction In Canada

    Oct 1, 2017, 00:00

  • Financial Group Incentives Improving Medication Persistence - Health Behavior Engineering Approach

    Oct 1, 2017, 00:00

  • Burden of Illness Associated With Anaemia In Chronic Kidney Disease In Japan- A Literature Review

    Oct 1, 2017, 00:00

  • Initiative To Obtain Advanced Therapeutic Outcomes In Multiple Myeloma (Importa Project)

    Oct 1, 2017, 00:00

  • Comparing The Estimated Health And Economic Benefits Of Herpes Zoster (HZ) Vaccines In The UK

    Oct 1, 2017, 00:00

  • Assessment of Hiv-Antiretroviral Adherence Using Refill Data From a National Administrative Database in Brazil

    Oct 1, 2017, 00:00

  • Representing Uncertainty In Economic Evaluations- Getting More From PSA Results

    Oct 1, 2017, 00:00

  • Using Network Meta-Analysis Of Individual Patient Data (IPD) Summary Aggregate Data (SAD) To Identify Which Combinations Of Interventions Work Best For Which Individuals

    Oct 1, 2017, 00:00

  • Providing A Framework For Assessing Access To Medicine

    Oct 1, 2017, 00:00

  • Using A Mixed Methods Approach To Determine The Item-Scale Structure and Scoring for Clinical Outcome Assessments

    Oct 1, 2017, 00:00

  • Hepatitis C Virus- Determinants Of Patients’ Management Costs

    Oct 1, 2017, 00:00

  • Comparison of The Long-Term Cost-Effectiveness of Ideglira Versus Multiple Daily Insulin Injections In The Spanish Setting Using Real-World Clinical Data

    Oct 1, 2017, 00:00

  • Evaluating the Long-Term Impact of Improving Care for Patients with Type 2 Diabetes in China

    Oct 1, 2017, 00:00

  • A Web-Based Hub Spoke Model For The Management Of HCV Patients And Innovative Treatments- The Resist - HCV Sicily Network Experience

    Oct 1, 2017, 00:00

  • Reporting Quality Transparency Of Published Network Meta-analysis. Is it Satisfactory?

    Oct 1, 2017, 00:00

  • Cost-Utility Of Novel Tests After A Negative Prostate Biopsy

    Oct 1, 2017, 00:00

  • What Are The Images Used To Diagnose And Assess Suspected Strokes?- A Systematic Literature Review Of Care In Four European Countries

    Oct 1, 2017, 00:00

  • Economic Analysis And Evaluation Of The Value Of The Parallel Export Of Medicinal Products For Treatment Of Oncological Diseases In Bulgaria, 2016 T. VEKOV 1 AND G. KOLEV2

    Oct 1, 2017, 00:00

  • Model Attention Improve The Hospital Nutrition Processes Under The Center Of Excellence Concept

    Oct 1, 2017, 00:00

  • A Quality-Adjusted Time without Symptoms of Disease And Toxicity (Q-TWIST) Analysis Comparing Nivolumab and Therapy Of Investigator’s Choice (IC) in Patients with Recurrent or Metastatic (R/M) Platinum-Refractory Squamous Cell Carcinoma of ...

    Oct 1, 2017, 00:00

  • Application Study of the EQ-5D-5L in Oncology- Linking Self-Reported Quality of Life of Patients with Metastatic Colorectal Cancer to Clinical Data from a German Tumor Registry

    Oct 1, 2017, 00:00

  • Costs of Grade 3 and 4 Adverse Events Associated with Current Cancer Treatments - Cost Estimations For Sweden, Norway, Finland And Denmark

    Oct 1, 2017, 00:00

  • Bayesian Methodology Considering Historical Data To Predict Overall Survival From Immature Trial Data In Oncology

    Oct 1, 2017, 00:00

  • Economic Evaluation For Establishing Stroke Unit Followed By Early Supported Discharge In Egypt

    Oct 1, 2017, 00:00

  • Health-Related Quality of Life in Oncology – Are we Getting Better?

    Oct 1, 2017, 00:00

  • Potential Therapeutic and Economic Value of Risk-Stratified Treatment as Initial Treatment of Multiple Myeloma in Europe

    Oct 1, 2017, 00:00

  • Drug-Safety Program Impact In The Emergency Frequency At Patients With Persistent Severe Asthma

    Oct 1, 2017, 00:00

  • A Predictive Tool For Characterizing And Visualizing Populations Under Counterfactual Treatment Assignment

    Oct 1, 2017, 00:00

  • Chronic Heart Failure (CHF) In The Czech Republic- Cost-of-Illness Analysis Disease Burden Based on Ahead Registry Data Mining

    Oct 1, 2017, 00:00

  • Varying Nature Of The Assessment Of Advanced Medicinal Products (Atmp) In Germany

    Oct 1, 2017, 00:00

  • Pharmacoeconomics Analysis of Sertindole Use In The Treatment of Schizophrenia In Russia

    Oct 1, 2017, 00:00

  • Financial Consequences of The Performance of A Pd-L1 Test To Select Patients Receiving Second and Third Line Treatments for Non-Small Cell Lung Cancer in Italy

    Oct 1, 2017, 00:00

  • Transfusion Trends In Primary and Revision Total Joint Arthroplasty- Are Recent Declines Shared Equally?

    Oct 1, 2017, 00:00

  • Surveillance Status, Diagnostic Accuracy And Survival Of The National Liver Cancer Surveillance Program

    Oct 1, 2017, 00:00

  • Quality of Life for Patients with Neurofibromatosis Type 1 Associated Plexiform Neurofibromas (PNF)

    Oct 1, 2017, 00:00

  • Impact of Golimumab, An Anti-Tnfα Monoclonal Antibody, On Health Related Quality of Life (Hrqol) And Work Productivity In Patients With Active Psoriatic Arthritis- 24-Week Results of The Phase Iii Go Vibrant Trial

    Oct 1, 2017, 00:00

  • Antibiotic Stewardship Policy in Biella General Hospital (Italy)- A Five-Year Surveillance

    Oct 1, 2017, 00:00

  • Differences In Vaccine Pricing Between High-Income And Low-Income Markets

    Oct 1, 2017, 00:00

  • Burden of Disease for Rheumatoid Arthritis In Argentina, Brazil, Colombia, Mexico and Venezuela

    Oct 1, 2017, 00:00

  • Challenges in Optimising Real World Evidence for Alzheimer’s Disease

    Oct 1, 2017, 00:00

  • Measuring The Impact Of The Food And Drug Administration (Fda) Unapproved Drug Initiative (Udi) On Drug Prices And Expenditures

    Oct 1, 2017, 00:00

  • Quantifying The Relationship Between Hyperkalaemia And Outcomes In Patients With Heart Failure Or Chronic Kidney Disease

    Oct 1, 2017, 00:00

  • Treatment Patterns Among Newly Diagnosed Diabetes Patients in Dubai

    Oct 1, 2017, 00:00

  • The Economic Burden of Chronic Obstructive Pulmonary Disease In The Spanish Region of Extremadura

    Oct 1, 2017, 00:00

  • Exenatide In Obese Or Overweight Patients Without Diabetes- A Systematic Review And Meta-Analyses Of Randomized Controlled Trials

    Oct 1, 2017, 00:00

  • The Impact Of The Study Design Submitted For The Early Benefit Assessment On The Pricing For Oncologic Drugs

    Oct 1, 2017, 00:00

  • Analysis of Oral Hypoglycemic Drugs Consumption in Ukraine in 2015

    Oct 1, 2017, 00:00

  • Health Economics And Outcomes Research Needs Assessment For Latin America- Relationship Between Perceived And Expected Quality Of Knowledge In A Self-Assessment Survey

    Oct 1, 2017, 00:00

  • Cross-Cultural Adaptation And Validation Of The PEDSQL Cardiac Module Version 3.0

    Oct 1, 2017, 00:00

  • South West Icers – The Experience of Nice’s Diagnostics Assessment Programme

    Oct 1, 2017, 00:00

  • Federal Spending on Infliximab in Brazil- An Analysis of Purchases from 2007-2015

    Oct 1, 2017, 00:00

  • Economic Impact of Alirocumab In The Management of Primary Hypercholesterolemia or Mixed Dyslipidemia- An Italian Perspective

    Oct 1, 2017, 00:00

  • Evaluating Physicians’ Perception Of Limitations And Obstacles Against The Effectiveness Of “Audit And Feedback” And “Printed Educational Materials” Interventions On Prescribing Behavior- A Qualitative Study

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of Mechanical Thrombectomy In Acute Phase Of Ischemic Stroke (AIS)

    Oct 1, 2017, 00:00

  • Functional Assessment After Treatment Of Upper Extremity Soft Tissue Sarcomas Using Structured Outcome Measures- A Systematic Review

    Oct 1, 2017, 00:00

  • Loss Of Response Of Anti TNF-Α Agents As The Second-Line Therapy In Inflammatory Bowel Disease- Based On Korean National Insurnance Claims Data

    Oct 1, 2017, 00:00

  • Economic Burden of Cardiovascular Disease In Type 2 Diabetes- A Systematic Review

    Oct 1, 2017, 00:00

  • Non Adherence to Inhalational Medications and Associated Factors Among Patients with Asthma in A Referral Hospital in Ethiopia, Using Validated Tool Tai

    Oct 1, 2017, 00:00

  • Reporting Clinical Outcomes In Tavi Registries

    Oct 1, 2017, 00:00

  • Value Of A Pilot Study In A Retrospective Chart Review- Final Protocol Design Should Base On Pilot Results

    Oct 1, 2017, 00:00

  • Análise De Custo Minimização Na Substituição De Infliximabe Por Seu Biossimilar No Sistema De Saúde Suplementar Brasileiro

    Oct 1, 2017, 00:00

  • Reliability Testing Of The Finnish Version Of The Non-Technical Skills Scale For Trauma (T-Notechs)

    Oct 1, 2017, 00:00

  • Influência Dos Fatores Socioeconômicos Na Incidência De Câncer De Mama- Revisão Sistemática

    Oct 1, 2017, 00:00

  • Antihypertensive Drug Prescription Patterns and their Impact on Outcome of Blood Pressure in Ethiopia-A Hospital-Based Observational Study

    Oct 1, 2017, 00:00

  • What's the Reality of Real-World Evidence in Health Technology Appraisal?

    Oct 1, 2017, 00:00

  • Lower Hemoglobin (HB) Levels Negatively Impact Quality Of Life (QOL) Among Peritoneal Dialysis (PD) Patients- Results From A National Representative Cohort Study In Brazil (BRAZPD)

    Oct 1, 2017, 00:00

  • Pharmacoeconomic Analysis of Using Solifenacin And Modified-Release Tamsulosin Fixed Dose Combination for Treatment of Storage Symptoms Associated With Benign Prostatic Hyperplasia

    Oct 1, 2017, 00:00

  • New European Medical Device Directive (MDD) Comes Into Effect In 2020- Chances And Consequences For Stakeholders

    Oct 1, 2017, 00:00

  • Cost-Utility Of Liquid Chromatography -Tandem Mass Spectrometry (LC-MS/MS)-Based Urine Analyses To Improve Adherence To Antihypertensive Treatment

    Oct 1, 2017, 00:00

  • Aplicação Da Mcda Nas Tomadas De Decisão Sobre Investimento Em Saúde – Uma Revisão Sistemática

    Oct 1, 2017, 00:00

  • Rotavirus Vaccination May Reduce Acute Gastroenteritis Rates Across All Age Groups In England

    Oct 1, 2017, 00:00

  • A Cost-Effectiveness Analysis of A Physician-Implemented, Medication Screening Tool in Older Hospitalised Patients in Ireland

    Oct 1, 2017, 00:00

  • Prescription Analysis on Off-Label Drugs In Pediatric Patients Using The Claims Data of The National Health Insurance In Korea

    Oct 1, 2017, 00:00

  • Impact of Collaborative Coustomized Patient Education in Psychiatric Diseases

    Oct 1, 2017, 00:00

  • Comorbidities in Multiple Sclerosis- A Descriptive Longitudinal Clustering Analysis of Healthcare Resource Utilization Among MS Patients in IBM Explorys Database

    Oct 1, 2017, 00:00

  • Assessing The Burden of Disease In Peripheral And Axial Spondyloarthritis In Mexico

    Oct 1, 2017, 00:00

  • Economic Evaluations of Etanercept in Patients with Psoriasis and Psoriatic Arthritis in Spain- A Systematic Review

    Oct 1, 2017, 00:00

  • Patient-Preferred Design Features Of Tnf Inhibitor Self-Injection Devices- Insights From A Rheumatoid Arthritis Auto-Injector Preference Study

    Oct 1, 2017, 00:00

  • European Study on Acute Cough in Children- Results of Poland

    Oct 1, 2017, 00:00

  • Allowing Methadone’s Prescription To General Practitioners- A Positive Impact on The French Healthcare Insurance Expenditures

    Oct 1, 2017, 00:00

  • Treatment Switching and Power of ITT and RPSFTM

    Oct 1, 2017, 00:00

  • Expenditure On Non-Pharmaceutical Products In Ireland During A Period Of Healthcare Cost Containment

    Oct 1, 2017, 00:00

  • National Adoption of New Immunossupresants for Solid Organs and Stem Cells Transplantations

    Oct 1, 2017, 00:00

  • A Sistematic Review Of The Cost-Effectiveness Of Vaccinating Elderly With The 23-Valent Pneumococcal Polysaccharide Vaccine (Ppv23)

    Oct 1, 2017, 00:00

  • Ixekizumab Treatment Leads to Early Improvements in Health-Related Quality of Life Versus Ustekinumab

    Oct 1, 2017, 00:00

  • Situation of Rheumatoid Arthritis Patients Treated with Biologics In Germany Based on a Claims Data Analysis

    Oct 1, 2017, 00:00

  • A Real World Evidence Model To Compare Direct Oral Anticoagulants Safety Outcomes For Atrial Fibrillation Patients In Spain

    Oct 1, 2017, 00:00

  • Tocilizumab after A First-Line with Anti-Tnf in Rheumatoid Arthritis- A Cost-Consequence Analysis in the Italian Setting

    Oct 1, 2017, 00:00

  • Facilitators and Barriers to Adult Vaccination in South East Asia and Latin America

    Oct 1, 2017, 00:00

  • Quantity And Quality Of External Event Validation Procedures Performed In Published Health Economic Models In Obesity- Outcomes Of A Systematic Review

    Oct 1, 2017, 00:00

  • Health Valuation of Dialysis with the EQ-5D- Determinants of Discrepancy Between Patients and Society

    Oct 1, 2017, 00:00

  • Cost Implications Of Tedizolid Introduction For The Treatment Of Complicated Skin And Soft Tissue Infections In A Russian Multi-Field Hospital

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Ziprasidone Use In The Treatment of Schizophrenia In Russia

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Afatinib, Gefitinib, Erlotinib, and Pemetrexed-Based Chemotherapy as First-Line Treatments for Egfr Mutation Positive, Advanced Non-Small Cell Lung Cancer in China

    Oct 1, 2017, 00:00

  • Developing A Methodology For Using Acoustic Simulations Of Hearing Loss To Describe Health States

    Oct 1, 2017, 00:00

  • Utilization Patterns of Lipid-Lowering Therapies in Patients at High Risk for or with Atherosclerotic Cardiovascular Disease- A Population-Based Study in South Korea

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Of Radiofrequency Catheter Ablation Of Atrial Fibrillation Based On Real-World Data- Manual Or Robotic?”

    Oct 1, 2017, 00:00

  • Variation In Opioid Utilization By Physician Specialty And Payer Using A Linked Claims-Emr Database

    Oct 1, 2017, 00:00

  • Economic Burden Of Hospitalized Diarrheal Disease In Bangladesh

    Oct 1, 2017, 00:00

  • Survival Rates In Primary Hepatic Carcinoma Patients With Cirrhosis In South Korea- A Retrospective Analysis of 68,328 Patients In The National Cancer Registry

    Oct 1, 2017, 00:00

  • A Societal Utility Study to Elicit Values for Adverse Events and Surgical Complications in Moderate to Severe Crohn’s Disease in UK

    Oct 1, 2017, 00:00

  • Value Health With A Mobile APP- The Infant Health-Related Quality Of Life Instrument

    Oct 1, 2017, 00:00

  • The Burden Of Albinism- Creation Of A Questionnaire

    Oct 1, 2017, 00:00

  • Comparison Of Previous IPHA-HSE Agreement Effects On The Hta Assessment Process In Ireland (2009 – 2016)

    Oct 1, 2017, 00:00

  • The Practical Application of a Digital Therapeutic Education Platform for Cardiovascular Rehabilitation

    Oct 1, 2017, 00:00

  • The Impact Of Co-Morbidity On The Disease Burden Of VTE

    Oct 1, 2017, 00:00

  • Coverage-With-Evidence-Development (CED) In Germany- Status QUO

    Oct 1, 2017, 00:00

  • Antecipação Ao Rol De Procedimentos Da Agência Nacional De Saúde Suplementar- Impacto Orçamentário Da Incorporação De Um Novo Inibidor De Tirosina-Quinase

    Oct 1, 2017, 00:00

  • Use of Thalidomide In Erythematosus Lupus Treatment

    Oct 1, 2017, 00:00

  • Will It Blend? Incorporation Of IRP Within HTA Systems

    Oct 1, 2017, 00:00

  • How Much Sexual Violence Against Women Costs To Brazil?

    Oct 1, 2017, 00:00

  • Cost Saving Analysis of Encephalogram Bispectral Index Monitoring (Bis) During Ten Different Types of Elective Surgeries in Colombia

    Oct 1, 2017, 00:00

  • Cost-Utility of Idelalisib In Combination with Rituximab In Relapsed or Refractory Chronic Lymphocytic Leukemia

    Oct 1, 2017, 00:00

  • Pharmacoeconomic Systematic Evaluation of Bevacizumab Treatment for Advanced Non-Small Cell Lung Cancer in China

    Oct 1, 2017, 00:00

  • Secukinumab Vs. Adalimumab for the Treatment of Psoriatic Arthritis- A Cost Per Responder Analysis at 48 Weeks from an Argentinian Perspective

    Oct 1, 2017, 00:00

  • Establishing A Medication Error Reporting And Monitoring Programme In A Developing Country’s Tertiary Care Teaching Hospital

    Oct 1, 2017, 00:00

  • Factores Asociados A La Automedicación En Usuarios De Boticas Y Farmacias En Perú- Análisis De La Encuesta De Satisfacción De Los Servicios De Salud (ENSUSALUD) 2015

    Oct 1, 2017, 00:00

  • Evidence Map of Costs Studies In Cystic Fibrosis Since 2000

    Oct 1, 2017, 00:00

  • Health-Related Quality of Life of Patients with Osteoporosis Treated with Teriparatide

    Oct 1, 2017, 00:00

  • Estimation of The Health Benefit Associated With A Potential Denosumab-Induced Extension of Progression Free Survival In Multiple Myeloma Patients

    Oct 1, 2017, 00:00

  • Development Of A Mortality Risk Prediction Tool For Patients With Heart Failure Or Chronic Kidney Disease At Risk Of Hyperkalaemia

    Oct 1, 2017, 00:00

  • Burden Disease of Aortic Stenosis Associated in Patients Undergoing Transcatheter Aortic Valve Replacement

    Oct 1, 2017, 00:00

  • Are Pharmaceutical Companies Prioritizing Multi-Indication Drugs?

    Oct 1, 2017, 00:00

  • Low Density Lipoprotein Cholesterol (LDL-C) Target Goal Achievement Rate According to Physicians’ Compliance to Established Clinical Guidelines from National Cholesterol Education Program-Adult Treatment Panel (NCEP-ATP) and American Colleg ...

    Oct 1, 2017, 00:00

  • Resource Utilisation And Costs Associated With Intravenous Patient-Controlled Analgesia Morphine For Post-Operative Pain Management In A Teaching Hospital Setting In Ireland

    Oct 1, 2017, 00:00

  • How does high meld score increases total expenditure on health system? A micro-costing prospective cohort study

    Oct 1, 2017, 00:00

  • Assessment of Medicines For Very Rare Conditions- Review of A New Approach within The Scottish Medicines Consortium

    Oct 1, 2017, 00:00

  • Quality of Life of Pregnant Women in Russian Federation

    Oct 1, 2017, 00:00

  • Incidence of Psychiatric Disorders in Women WITH a Suspected But Unconfirmed Diagnosis of Breast or Genital Organ Cancer

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Alectinib Compared To Chemotherapy for The Treatment of Treatment-Naïve Patients With Alk Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) in Greece

    Oct 1, 2017, 00:00

  • ALK Immunohistochemical Test In The Detection Of Patients Affected By ALK+ Non-Small Cell Lung Cancer- Clinical And Budget Impact

    Oct 1, 2017, 00:00

  • Newly Diagnosed Multiple Myeloma (NDMM) Patient Profiles; Findings From An Observational Chart Review In France, Germany, Italy, Spain And The United Kingdom

    Oct 1, 2017, 00:00

  • Analyzing the Treatment Cost of Liver Cirrhosis from Healthcare Payer’s Perspective of Vietnam in 2015

    Oct 1, 2017, 00:00

  • Mejoramiento De Los Resultados Clínicos En Pacientes Con Reemplazos De Cadera Y Rodilla

    Oct 1, 2017, 00:00

  • Psoriasis Drugs in Europe - Market Access Decisions in Comparision Based on the Prismaccess Database

    Oct 1, 2017, 00:00

  • Inconclusive Eviden Can Pharmacoeconomics Tilt The Balance?

    Oct 1, 2017, 00:00

  • The Epidemiology and Burden of Paediatric Multiple Sclerosis- Systematic Literature Review

    Oct 1, 2017, 00:00

  • Analysis of Real Data for Treatment of Preterm Birth in Pregnant in Ukraine

    Oct 1, 2017, 00:00

  • Burden Of Illness Of Pulmonary Embolism In Europe – Healthcare Resource Utilization And Productivity Loss

    Oct 1, 2017, 00:00

  • A Review Of Economic Evaluations Considering Screening Interventions For The Risk Assessment Of Venous Thromboembolism In Women Considering Combined Oral Contraceptives

    Oct 1, 2017, 00:00

  • Comparison Of Post-Creation Procedures And Related Costs Between Traditional Surgical Versus A New Endovascular Approach To Creating An Arteriovenous Fistula- A Usrds Comparison

    Oct 1, 2017, 00:00

  • Psychometric Properties Of The EQ-5D-5L In Patients With Major Depression Disorder

    Oct 1, 2017, 00:00

  • A Systematic Review Of Economic Evaluations In Robot-Assisted Hysterectomy Use For Cervical Cancer Compared With Open And Laparoscopic Surgery

    Oct 1, 2017, 00:00

  • An Empirical Analysis of The Role of Learning by Doing in Dynamic Cost-Effectiveness

    Oct 1, 2017, 00:00

  • Treatment Satisfaction Among Patients with Moderate-to-Severe Plaque Psoriasis in Brazil

    Oct 1, 2017, 00:00

  • Value Frameworks For Cancer Care- Do They Account For Potential Durable Survival With Immunotherapy?

    Oct 1, 2017, 00:00

  • Oncologic Pain Attitudes, Intensity And Treatment In Brazil

    Oct 1, 2017, 00:00

  • When The Outcome of An Appraisal Is Not Ni A Review Of Nice Appeals

    Oct 1, 2017, 00:00

  • The Effect Of Chronic Diseases, Financial Hardship And Personality Types In Patient's Medication Adherence

    Oct 1, 2017, 00:00

  • Economic Burden Of Vaccine Preventable Infectious Diseases Among Elderly Patients In Dutch Hospitals

    Oct 1, 2017, 00:00

  • Systematic Review Of Statins Effectiveness In Prevention Secondary In Elderly

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of The Sufentanil Sublingual Tablet System Vs Iv Pca Morphine For The Treatment of Acute Moderate To Severe Post-Operative Pain In Ireland

    Oct 1, 2017, 00:00

  • Caracterización Del Riesgo Cardiovascular Por Factores Asociados- Análisis De Base De Datos De UNA Aseguradora Colombiana

    Oct 1, 2017, 00:00

  • Pump-Downloaded Insulin Usage For The First 12 Months In A Cohort of Children Newly-Diagnosed With Type 1 Diabetes (T1D)

    Oct 1, 2017, 00:00
  • «
  • 61
  • 62
  • 63 (current)
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • »